- Home
- USNA vs AUTL Comparison
USNA vs AUTL Comparison
Compare USNA & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USNA
- AUTL
- Stock Information
- Founded
- USNA 1992
- AUTL 2014
- Country
- USNA United States
- AUTL United Kingdom
- Employees
- USNA N/A
- AUTL N/A
- Industry
- USNA Medicinal Chemicals and Botanical Products
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- USNA Health Care
- AUTL Health Care
- Exchange
- USNA Nasdaq
- AUTL Nasdaq
- Market Cap
- USNA 648.2M
- AUTL 590.8M
- IPO Year
- USNA 1996
- AUTL 2018
- Fundamental
- Price
- USNA $31.55
- AUTL $2.17
- Analyst Decision
- USNA Hold
- AUTL Strong Buy
- Analyst Count
- USNA 1
- AUTL 3
- Target Price
- USNA $38.00
- AUTL $10.20
- AVG Volume (30 Days)
- USNA 123.0K
- AUTL 1.1M
- Earning Date
- USNA 02-25-2025
- AUTL 03-13-2025
- Dividend Yield
- USNA N/A
- AUTL N/A
- EPS Growth
- USNA N/A
- AUTL N/A
- EPS
- USNA 2.83
- AUTL N/A
- Revenue
- USNA $861,973,000.00
- AUTL $10,091,000.00
- Revenue This Year
- USNA N/A
- AUTL $851.83
- Revenue Next Year
- USNA $11.73
- AUTL $224.65
- P/E Ratio
- USNA $11.08
- AUTL N/A
- Revenue Growth
- USNA N/A
- AUTL 82.71
- 52 Week Low
- USNA $30.92
- AUTL $2.07
- 52 Week High
- USNA $52.75
- AUTL $7.37
- Technical
- Relative Strength Index (RSI)
- USNA 29.77
- AUTL 41.81
- Support Level
- USNA $33.92
- AUTL $2.11
- Resistance Level
- USNA $36.25
- AUTL $2.26
- Average True Range (ATR)
- USNA 1.04
- AUTL 0.12
- MACD
- USNA -0.17
- AUTL 0.01
- Stochastic Oscillator
- USNA 11.82
- AUTL 27.78
About USNA USANA Health Sciences Inc.
Usana Health Sciences Inc is a U.S.-based company that is principally engaged in developing, manufacturing, and selling science-based nutritional and personal-care products. The company operates through direct selling. It owns a number of product lines, such as Essentials, which contains core vitamin and mineral supplements; Optimizers, which includes targeted supplements for individuals' health and nutritional needs; Foods, which consists of low-glycemic meal replacement shakes, snack bars, and other related products; and Sense Beautiful Science, which contains personal-care products related to skin and hair. The company conducts business worldwide, including Asia-Pacific, the Americas, and Europe.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.